GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Pretax Margin %

Avicanna (TSX:AVCN) Pretax Margin % : -50.40% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Avicanna Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Avicanna's Pre-Tax Income for the three months ended in Dec. 2023 was C$-3.05 Mil. Avicanna's Revenue for the three months ended in Dec. 2023 was C$6.05 Mil. Therefore, Avicanna's pretax margin for the quarter that ended in Dec. 2023 was -50.40%.

The historical rank and industry rank for Avicanna's Pretax Margin % or its related term are showing as below:

TSX:AVCN' s Pretax Margin % Range Over the Past 10 Years
Min: -13836.9   Med: -2232.42   Max: -52.06
Current: -52.06


TSX:AVCN's Pretax Margin % is ranked worse than
81.27% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.33 vs TSX:AVCN: -52.06

Avicanna Pretax Margin % Historical Data

The historical data trend for Avicanna's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Pretax Margin % Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial -13,836.90 -2,232.42 -512.73 -364.01 -52.07

Avicanna Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -575.97 -214.36 -53.06 -22.77 -50.40

Competitive Comparison of Avicanna's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Avicanna's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avicanna's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avicanna's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Avicanna's Pretax Margin % falls into.



Avicanna Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Avicanna's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-8.743/16.791
=-52.07 %

Avicanna's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-3.051/6.053
=-50.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avicanna  (TSX:AVCN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Avicanna Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Avicanna's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avicanna (TSX:AVCN) Business Description

Traded in Other Exchanges
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.
Executives
Sheldon Inwentash 10% Security Holder

Avicanna (TSX:AVCN) Headlines

No Headlines